JPRN-UMIN000010447已完成未知
Comparison of ultralongacting insulin, glargine and degludec in type2 diabetes - Comparison of ultralongacting insulin, glargine and degludec
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 70
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 85years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)severe ketosis, diabetic coma within 6 months 2)severe infection, before operation, severe trauma 3)severe hepatic dysfunction 4)or severe renal dysfunction (SCr:more than 2.0mg/dl or eGFR less than 30) 5)pregnacy 6)Allergy for glargine and degludec 7)Patients judged by the investigator to be ineligible for some other reason
研究者
相似试验
已完成
不适用
Comparison of ultralongacting insulin, glarugine and degludec in type 2 diabetes under basal-bolus insulin treatmenttype 2 diabetesJPRN-UMIN000010518aga Municipal Hospital30
已完成
3 期
Comparision of glargine insulin and Regular insulin on quality of perioperative glucose controlType 2 diabetes mellitus.Type 2 diabetes mellitusIRCT20141127020112N8Iran University of Medical Sciences80
招募中
不适用
Comparison of insulin glargine and insulin degludec in type 2 diabetes by continuous glucose monitoring systemtype 2 diabetesJPRN-UMIN000010715Mie Chuo Medical Center30
进行中（未招募）
不适用
Comparative investigation of Insuline glargine versus Metformin as first line drug in treat-ment of early Type 2 Diabetes (GLORY) - GLORYDiabetes mellitus Type IIMedDRA version: 9.1Level: LLTClassification code 10045242Term: Type II diabetes mellitusEUCTR2008-006860-12-DEGWT-TUD GmbH100
招募中
不适用
Comparison between long acting insulin analogue and biphasic insulin aspart30/70 (BIAsp 30) as combination therapy with oral anti-diabetic agents.Patients with type 2 diabetes mellitusJPRN-UMIN000005194ational Hospital Organization, Okayama Medical Center30